Strength
320 mg/2mL
Manufacturer
UCB, Inc.NDC
50474078284
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
1/1/2026
Active Ingredients
BIMEKIZUMABApproval Type
Biologic (BLA)
FDA Application
BLA761151On Market Since
12/5/2024
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
No related drugs found.